Moleculin Biotech, Inc (MBRX) Stock Price

0.4928 ▼ -0.0269 (-5.18%)
Open: 0.4901 Vol: 0 Day's range: 0.4729 - 0.4994 Nov 04, 11:17 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MBRX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.49▲ 0.49▼ 0.51▼ 0.48▲ 0.49▲
MA10 0.49▲ 0.51▼ 0.50▼ 0.48▲ 0.45▲
MA20 0.49▲ 0.50▼ 0.48▲ 0.49▲ 0.50▼
MA50 0.51▼ 0.47▲ 0.48▲ 0.45▲ 0.99▼
MA100 0.50▼ 0.48▲ 0.49▲ 0.51▼ 3.07▼
MA200 0.48▲ 0.48▲ 0.48▲ 0.79▼ 9.72▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.004▼ 0.003▲ 0.000▲ 0.049▲
RSI 47.502▼ 50.472▲ 52.589▲ 51.745▲ 42.137▼
STOCH 61.393     23.905     35.303     36.709     45.397    
WILL %R -24.906▲ -81.277▼ -72.514     -68.600     -61.997    
CCI 60.682     -78.075     9.467     4.221     24.392    
Latest Filters Detected On MBRX
▲ MACD $MBRX MACD(12,26,9) Crossed Above Signal Line Set Alert
▼ GAP $MBRX Open Gap Down %5 Set Alert
▼ GAP $MBRX Open Gap Down %3 Set Alert
▼ GAP $MBRX Open Gap Down %2 Set Alert
CDL $MBRX Harami Candlestick Pattern Detected Set Alert
CDL $MBRX Doji Candlestick Pattern Detected Set Alert
Moleculin Biotech, Inc News
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting
Thursday, October 30, 2025 05:50 AM
For more information about the 14 th Annual Acute Leukemia Meeting, please visit the meeting website. About Moleculin Biotech, Inc.
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
Wednesday, October 29, 2025 05:53 AM
Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral ...
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
Thursday, October 23, 2025 05:15 AM
Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic ...
MBRX historical stock data
date open high low close volume
04/11/25 0.4901 0.4994 0.4729 0.4928 1,716,153
03/11/25 0.454 0.63 0.4427 0.5197 23,318,506
31/10/25 0.4418 0.48 0.43 0.4654 3,401,544
30/10/25 0.525 0.5375 0.4327 0.4518 43,693,889
29/10/25 0.4822 0.50 0.4654 0.4796 1,551,739
28/10/25 0.49 0.498 0.4774 0.4829 1,042,909
27/10/25 0.49 0.51 0.4598 0.4959 1,796,897
24/10/25 0.4904 0.5038 0.48 0.486 1,953,673
23/10/25 0.4917 0.52 0.4681 0.4904 4,350,104
22/10/25 0.4777 0.4777 0.4397 0.4466 2,074,075
Quote Details
52wk Low:0.25
52wk High:3.65
Vol:0
Avg Vol(3m):59.6M
1Y Chng:-81.15%
1M Chng:+15.76%
Add to Watch List
More Information
Index US Composite
Market Cap. 23.04M